OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE

BLOG

ALL POSTS
May, 25 2023

BILINGUALISM REQUIREMENT FOR MEDICINES IN ...

The Italian Decree n. 219/2006 (implementing 2001/83/EC Directive and following amendments) establishes that at least the informat...

READ
May, 18 2023

CRITERIA FOR MARKETING AUTHORIZATION (MA) ...

The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) has provided Marketing Authorization Holders (MAH) with the crit...

READ
May, 04 2023

AIFA REPORT ON TIMELINES FOR PRICING AND R...

On 27 April 2023, the Italian Medicines Agency (AIFA) published a report on the timelines of "Pricing and Reimbursement" procedure...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY